CliffBio
small molecule

VEVYE

CYCLOSPORINE

Loss of exclusivityApril 2042latest FDA-listed patent expiry
CompanyHARROW EYE LLC

Drug detail

Brand nameVEVYE
Active ingredientCYCLOSPORINE
Strength0.1%
Dosage formSOLUTION
RouteOPHTHALMIC
ModalitySmall molecule
FDA approvalMay 2023
Marketing statusRX

Listed patents

PatentExpiresType
12059449April 2042product
11413323October 2039use U-3627
10813976September 2037product
12496326September 2036use U-3627
8614178December 2030product

Regulatory exclusivity

CodeExpires
NPMay 2026

More from HARROW EYE LLC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.